Compare Immunovant Inc. Common Stock (IMVT) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while KraneShares Electric Vehicles and Future Mobility trades at $27.56 (market cap $74.06M). The key difference: Immunovant Inc. Common Stock is far larger — about 89.4× KraneShares Electric Vehicles and Future Mobility's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and KraneShares Electric Vehicles and Future Mobility for 46 Days on average.
| IMVT | KARS | |
|---|---|---|
Market Cap | $6.62B | $74.06M |
Volume | 1,131,364 | 2,546 |
Sector | Health | Sector/Thematic |
52-Week High | $44.96 | $38.01 |
52-Week Low | $17.03 | $27.25 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $5.72B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
